Transcat (NASDAQ:TRNS) released its quarterly earnings data on Tuesday. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.09, Fidelity Earnings reports. The firm had revenue of $44.49 million for the quarter, compared to analyst estimates of $41.90 million. Transcat had a net margin of 4.44% and a return on equity of 13.05%.

Transcat stock opened at $25.10 on Thursday. The company has a market capitalization of $173.81 million, a price-to-earnings ratio of 25.38, a P/E/G ratio of 2.97 and a beta of 0.90. The company has a current ratio of 2.16, a quick ratio of 1.45 and a debt-to-equity ratio of 0.40. Transcat has a twelve month low of $17.30 and a twelve month high of $26.96.

TRNS has been the topic of several research reports. ValuEngine upgraded shares of Transcat from a “hold” rating to a “buy” rating in a research note on Monday, February 4th. Zacks Investment Research upgraded shares of Transcat from a “hold” rating to a “buy” rating and set a $25.00 price objective on the stock in a research note on Saturday, February 2nd.

Institutional investors have recently added to or reduced their stakes in the business. Marshall Wace North America L.P. increased its stake in Transcat by 157.5% in the 1st quarter. Marshall Wace North America L.P. now owns 1,545 shares of the scientific and technical instruments company’s stock valued at $36,000 after buying an additional 945 shares during the period. Morgan Stanley acquired a new position in shares of Transcat during the 1st quarter worth $36,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Transcat during the 1st quarter worth $62,000. JPMorgan Chase & Co. acquired a new position in shares of Transcat during the 1st quarter worth $104,000. Finally, Howe & Rusling Inc. increased its stake in shares of Transcat by 2,375.0% during the 4th quarter. Howe & Rusling Inc. now owns 4,950 shares of the scientific and technical instruments company’s stock worth $94,000 after purchasing an additional 4,750 shares during the last quarter. Hedge funds and other institutional investors own 58.21% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Transcat (TRNS) Issues Quarterly Earnings Results” was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://theolympiareport.com/2019/05/23/transcat-trns-issues-quarterly-earnings-results.html.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Featured Article: Moving Average – How it Helps Investors in Stock Selection

Earnings History for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.